Massachusetts Financial Services’s Aratana Therapeutics, Inc. PETX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,590,967	Closed	-$5.73M	–	884
2019 Q1	$5.73M	Buy	1,590,967 +91,800	+6%	+$398K	﹤0.01%	656
2018 Q4	$9.19M	Buy	1,499,167 +7,971	+0.5%	+$48.6K	﹤0.01%	609
2018 Q3	$8.71M	Buy	1,491,196 +114,998	+8%	+$575K	﹤0.01%	644
2018 Q2	$5.85M	Buy	1,376,198 +365,750	+36%	+$1.84M	﹤0.01%	669
2018 Q1	$4.46M	Buy	1,010,448 +10,404	+1%	+$46.4K	﹤0.01%	672
2017 Q4	$5.26M	Buy	1,000,044 +9,341	+0.9%	+$57.1K	﹤0.01%	662
2017 Q3	$6.07M	Buy	990,703 +6,009	+0.6%	+$38K	﹤0.01%	655
2017 Q2	$7.12M	Sell	984,694 -205	-0%	-$1.26K	﹤0.01%	650
2017 Q1	$5.22M	Sell	984,899 -1,429	-0.1%	-$9.65K	﹤0.01%	650
2016 Q4	$7.08M	Sell	986,328 -2,444	-0.2%	-$19.8K	﹤0.01%	633
2016 Q3	$9.26M	Buy	988,772 +16,837	+2%	+$140K	﹤0.01%	588
2016 Q2	$6.14M	Buy	971,935 +47,102	+5%	+$303K	﹤0.01%	620
2016 Q1	$5.11M	Buy	924,833 +11,705	+1%	+$44K	﹤0.01%	640
2015 Q4	$5.09M	Sell	913,128 -6,495	-0.7%	-$42.9K	﹤0.01%	651
2015 Q3	$7.78M	Sell	919,623 -60,864	-6%	-$1.03M	﹤0.01%	624
2015 Q2	$14.8M	Sell	980,487 -14,562	-1%	-$210K	0.01%	568
2015 Q1	$15.9M	Sell	995,049 -115,263	-10%	-$2.05M	0.01%	570
2014 Q4	$19.8M	Sell	1,110,312 -136,091	-11%	-$1.7M	0.01%	530
2014 Q3	$12.5M	Buy	1,246,403 +268,284	+27%	+$3.25M	0.01%	611
2014 Q2	$15.3M	Buy	978,119 +149,919	+18%	+$2.12M	0.01%	577
2014 Q1	$15.4M	Buy	+828,200	New	+$16.6M	0.01%	538